🇺🇸 cholecalciferol (vitamin D3) in United States

157 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 157

Most-reported reactions

1. Nausea — 29 reports (18.47%)
2. Dyspnoea — 18 reports (11.46%)
3. Fatigue — 17 reports (10.83%)
4. Headache — 15 reports (9.55%)
5. Asthenia — 14 reports (8.92%)
6. Diarrhoea — 14 reports (8.92%)
7. Abdominal Pain — 13 reports (8.28%)
8. Arthralgia — 13 reports (8.28%)
9. Dizziness — 13 reports (8.28%)
10. Vomiting — 11 reports (7.01%)

Source database →

Frequently asked questions

Is cholecalciferol (vitamin D3) approved in United States?

cholecalciferol (vitamin D3) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for cholecalciferol (vitamin D3) in United States?

Medical University of South Carolina is the originator. The local marketing authorisation holder may differ — check the official source linked above.